BioSpace News Archive

Romark, a research-based pharmaceutical company focused on the discovery, development and delivery of innovative new medicines, primarily in the field of infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s manufacturing facility in Manati, Puerto Rico for the production of

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets announced that it has filed its submission for an Emergency Use Authorization (EUA) for its Covid-19 IgG ELISA antibody test with the FDA. This test will determine which individuals within the population have been exposed to the SARS-CoV-2 virus. The transfer of production to our facility in Jame

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia’s paxalisib (formerly GDC-0084) for the treatment of glioblastoma, the most common and most aggressive for

Immunovia has today published second quarter interim report for January - June 2020 . It is available on Immunovia’s website . “During Q2, we successfully handled COVID-19 challenges beyond our control, strengthened the company’s economic position, began the expansion of our sales, marketing, and customer service organizatio

Philadelphia and its surrounding counties issued a series of “stay-at-home” orders on March 17, 2020 in an effort to curb the spread of COVID-19.

Clinical Study Demonstrates No Adhesion Formation at Second-Look Hysteroscopy Performed Six Weeks After Transcervical Fibroid Ablation with the Sonata System REDWOOD CITY, Calif.--( BUSINESS WIRE )-- Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of the OPEN clinical trial results, demonstrating a lack of intrauterine adhesion formation af

Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, and Impact Therapeutics, a privately held clinical-stage biopharmaceutical company devoted to the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, annouced today that they reached a strategic agreement to esta

Since COVID-19 emerged late last year, there’s been an enormous amount of research produced on this novel coronavirus disease.

Qosina is pleased to offer 3D-printed nasopharyngeal swabs, plus anterior nares swabs for nasal mucosa specimen collection during COVID-19 testing. For questions regarding these U.S.-made, high quality swabs, email sales@qosina.com . This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200820005578/en/ (Photo: Business Wire) Qosina also carries 57 uniq

Telligen, a 100 percent employee-owned ESOP company, announces the appointment of Bruce P. Beddow, JD to its board of directors.